Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)

NCT04155034 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT04155034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04155034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 4, 2020
Completion date
November 15, 2029
Enrollment
668 (estimated)
Sites
446

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage lung small cell carcinoma, limited stage lung small cell carcinoma, lung small cell carcinoma